Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

Question 2

How does CYB003 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the dosing and support sessions involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific lifestyle changes I need to make while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder clinical trial (NCT06793397). Contact the study team or your healthcare provider for specific answers.

What this study is about